Intravenous Theophylline Therapy: Nomogram Guidelines

  1. WILLIAM J. JUSKO, Ph.D.;
  2. JEFFREY R. KOUP, Pharm.D.;
  3. JOHN W. VANCE, M.D.;
  4. JEROME J. SCHENTAG, Pharm.D.; and
  5. PAUL KURITZKY, M.D.
  1. Buffalo, New York

    Abstract

    We evolved a nomogram for guiding and standardizing intravenous theophylline therapy in hospitalized patients. It provides rapid calculation of a loading dose based on body weight and previous therapy and a maintenance infusion rate related to three categories of expected metabolic activity. The guidelines were prospectively used in the treatment of 72 patients, mainly in a respiratory care unit. The nomogram was successfully used to attain near-steady-state serum concentrations in the therapeutic range of 8 to 20 mg/litre in 72% of patients, with only two patients outside of the range of 5 to 25 mg/litre. These guidelines facilitate initial theophylline dosage in older patients with liver and cardiac disease and provide a rational basis for interpreting serum concentration measurements and adjustment of drug therapy.

    Article and Author Information

    • ▸From the Departments of Pharmaceutics and Medicine, Schools of Pharmacy and Medicine, State University of New York at Buffalo, and Millard Fillmore Hospital; Buffalo, New York.

    • Grant support: in part by Grant No. 20852 from the National Institutes of General Medical Sciences, National Institutes of Health.

    • ▸Requests for reprints should be addressed to William J. Jusko, Ph.D.; Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital; Buffalo, NY 14209.

      • Received August 9, 1976.
      • Accepted December 14, 1976.
    « Previous | Next Article »Table of Contents